Natus Medical (NASDAQ:NTUS) is scheduled to post its quarterly earnings results after the market closes on Thursday, October 24th. Analysts expect Natus Medical to post earnings of $0.38 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Natus Medical (NASDAQ:NTUS) last issued its earnings results on Thursday, July 25th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.04. The business had revenue of $125.54 million for the quarter, compared to analyst estimates of $122.85 million. Natus Medical had a negative net margin of 7.38% and a positive return on equity of 10.73%. On average, analysts expect Natus Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Shares of NASDAQ NTUS opened at $32.41 on Wednesday. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of 22.82 and a beta of 0.73. Natus Medical has a 12-month low of $22.25 and a 12-month high of $35.73. The business’s fifty day moving average is $30.76. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.36 and a current ratio of 1.93.
About Natus Medical
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.
Featured Story: The components of the Stochastic Momentum Index
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.